ResultsIQ › Latest results › Fermenta Biotech Limited
Fermenta Biotech Limited Q1 FY26 results deck summary
NSE: FERMENTA · BSE: 506414
Results deck of 13 Aug 2025, summarised by AI from the filing.
Consolidated profit after tax ₹21.6 cr (Q1FY25: ₹5.9 cr loss, down 35% QoQ), including Real Estate.
Key takeaways
- PAT Consolidated profit after tax ₹21.6 cr (Q1FY25: ₹5.9 cr loss, down 35% QoQ), including Real Estate.
- Human nutrition Human nutrition volume grew 83% over Q1FY25 and 8% over Q4FY25.
- German subsidiary German subsidiary standalone Q1FY26 revenue ₹15.7 cr, up 588% from ₹2.3 cr a year ago and 35% over previous quarter.
Fermenta Biotech Limited Q1 FY27 results
As filed: Revenue ₹112 cr, EBITDA ₹23.0 cr, PAT ₹15.0 cr, EBITDA margin 20.6%.
Not scored. No result for the same quarter last year.
Fermenta Biotech Limited earnings call, investor presentation and press release summaries
- Q1 FY27: Results deck (11 Aug 2026), Results press release (11 Aug 2026)
- Q4 FY26: Results deck (26 May 2026), Results press release (26 May 2026)
- Q3 FY26: Results deck (11 Feb 2026), Results press release (9 Feb 2026)
- Q2 FY26: Results deck (12 Nov 2025), Results press release (11 Nov 2025)
- Q1 FY26: Results deck (13 Aug 2025)
- Q4 FY25: Results deck (4 Jun 2025), Results press release (28 May 2025)
Figures from the company's filings with NSE and BSE. Not investment advice.